Management of patients with abnormal uterine bleeding puberty in the outpatient setting (experience MCDC “Yuventa”)


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Questions of the effectiveness of therapy of abnormal uterine bleeding puberty, prevention of recurrence and restore of normal menstrual and fertility are extremely important in the future. Diagnosis of abnormal uterine bleeding puberty often is an absolute indication for hospitalization. However, the experience Saint Petersburg Municipal consultive and diagnostic center “Juventa” patients can receive medical treatment in a day hospital with good clinical effect, if they haven’t anemia and heavy bleeding. Аccording to Juventa clinic, dysfunctional uterine bleedings of the pubertal period iconsist 4 % in the structure of the gynaecological diseases among the young girls. 75-89 % of young patients with bleedings do not require hospitalization with 24 hour observation and can get medical care in the outpatient settings with good clinical effect. In 2/3 of patients could receive the hemostatic effect when using a non-hormonal therapy. In 1/3 of patients require hormone therapy. All of the patients need further medical supervision and therapy for prevention of recurrent bleeding. The effectiveness of conservative hemostatic therapy conducted in a day hospital was 97.8 %. Important conditions for a good clinical effect were: patient selection, which can be performed outpatient treatment, the use of complex therapy, dynamic assessment of the effectiveness of the therapy, timely correction of the treatment regimen with the addition of hormone hemostatic therapy.

全文:

受限制的访问

作者简介

Irina Gogotadze

Saint Petersburg State Pediatric Medical University

Email: irinagogotadze@rambler.ru
MD, PhD, Associate Professor. Department of Сhildren Gynecology and Women Reproductology

Pavel Krotin

St. Petersburg State Municipal consultive and diagnostic centre “Yuventa”

Email: pkrotin@rambler.ru
MD, PhD, Dr Med Sci, Professor, Head

Tat’yana Kozhukhovskaya

St. Petersburg State Municipal consultive and diagnostic centre “Yuventa”

Email: tatianako@inbox.ru
MD, PhD

Elena Bogatyreva

Saint Petersburg State Pediatric Medical University

Email: Elen_bogat@mail.ru
Postgraduate Student, Department of Children Gynecology and Women Reproductology

参考

  1. Веселова Н. М. Особенности дифференцированного применения гормонального и негормонального метода лечения у девочек подростков с маточными кровотечениями пубертатного возраста. Биол. медицина. 2007; 13 (2): 35-42.
  2. Гоготадзе И. Н. Ювенильные кровотечения. Методическое пособие. СПб.: СПб ГПМА; 2004.
  3. Гуркин Ю. А. Детская и подростковая гинекология: Руководство для врачей. М: МИА. 2009; 268-301.
  4. Коколина В. Ф. Детская и подростковая гинекология. М.: Медпрактика-М. 2006; 174-228.
  5. Коколина В. Ф. Гинекологическая эндокринология детского и подросткового возраста: Руководство для врачей. 4-е изд. М.: Медпрактика-М. 2005: 174-89.
  6. Кулаков В. И., Уварова Е. В. Стандартные принципы обследования и лечения детей и подростков с гинекологическими заболеваниями и нарушениями полового развития. М.: Триада-Х. 2004.
  7. Lethaby A., Augood C., Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2002; (1).
  8. Lethaby A., Farquhar C., Cooke I. Antifibrinolitics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000; (4).
  9. Pediatric and Adolescent gynecology. In: Evidence-based Clinical Practice / C. Sultan (ed.). Montpellier 2004; 270.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Gogotadze I.N., Krotin P.N., Kozhukhovskaya T.Y., Bogatyreva E.M., 2015

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


##common.cookie##